Based on high demand expected to continue throughout the year and a very strong first quarter of 2021 with net sales of EUR 4.63 bn resulting in EBITDA pre of EUR 1.51 bn and EPS pre of EUR 2.18, Merck ...
Disclosure of inside information pursuant to Article 17 of the Regulation (EU) No 596/2014
Based on high demand expected to continue throughout the year and a very strong first quarter of 2021 with net sales of EUR 4.63 bn resulting in EBITDA pre1 of EUR 1.51 bn and EPS pre1 of EUR 2.18, Merck KGaA (the “Company”) has raised its forecast for the entire group for fiscal 2021. The Company now projects net sales of approx. EUR 18.5 – 19.5 bn (previously “strong organic growth”). EBITDA pre1 is anticipated to grow to approx. EUR 5.4 – 5.8 bn for the group (previously “organic: high single-digit to low teens growth”). EPS pre1 is projected to amount to approx. EUR 7.50 – 8.20.
The Company will publish first-quarter 2021 figures as scheduled on 12 May 2021.
www.merckgroup.comm
